Cargando…
Eicosanoids in Cancer: Prostaglandin E(2) Receptor 4 in Cancer Therapeutics and Immunotherapy
The cyclooxygenase-2 (COX-2) enzyme is frequently overexpressed in epithelial malignancies including those of the breast, prostate, lung, kidney, ovary, and liver and elevated expression is associated with worse outcomes. COX-2 catalyzes the metabolism of arachidonic acid to prostaglandins. The COX-...
Autores principales: | Ching, Mc Millan, Reader, Jocelyn, Fulton, Amy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273839/ https://www.ncbi.nlm.nih.gov/pubmed/32547404 http://dx.doi.org/10.3389/fphar.2020.00819 |
Ejemplares similares
-
The Role of Eicosanoids in Gynecological Malignancies
por: Smith, Paige G., et al.
Publicado: (2020) -
Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties
por: Kundu, Namita, et al.
Publicado: (2013) -
Editorial: Eicosanoids in Cancer
por: Markosyan, Nune, et al.
Publicado: (2021) -
A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE(2)-mediated immunosuppression and inhibits breast cancer metastasis
por: Ma, Xinrong, et al.
Publicado: (2013) -
Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer
por: Kochel, Tyler J, et al.
Publicado: (2016)